1.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(9): 829-829, oct. 2023. ilus
Artigo
em Espanhol
| IBECS
| ID: ibc-226044
2.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(9): t829-t829, oct. 2023. ilus
Artigo
em Espanhol
| IBECS
| ID: ibc-226045
3.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(3): 257-258, mar. 2023. ilus
Artigo
em Espanhol
| IBECS
| ID: ibc-217040
4.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(3): t257-t258, mar. 2023. ilus
Artigo
em Inglês
| IBECS
| ID: ibc-217041
5.
Actas Dermosifiliogr
; 114(9): 829, 2023 10.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-36740180
6.
Actas Dermosifiliogr
; 114(3): 257-258, 2023 03.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-35753365
7.
Primary lymphocytic lymphoma of lacrimal gland. / Linfoma linfocítico primario de glándula lagrimal.
Arch Soc Esp Oftalmol
; 92(2): 82-85, 2017 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-27268701
RESUMO
CASE REPORT: We report a case of primary small-cell lymphocytic lacrimal gland lymphoma in a male diagnosed with primary antiphospholipid syndrome. These rare lymphomas are usually presented in the clinic as disseminations secondary to chronic lymphocytic leukaemia, and the primary site is rare in the orbit. DISCUSSION: Non-Hodgkin lymphomas are a heterogeneous group of tumours. Although treatment in the IE stage is usually radiotherapy, due to its association with antiphospholipid syndrome, systemic treatment with rituximab was administered.